Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation
Sushila A. Toulmin(University of Pennsylvania), Laurence C. Eisenlohr(Children's Hospital of Philadelphia), Andrew J. Paris(University of Pennsylvania), Maria C. Basil(Boston University), Edward E. Morrisey(Penn Center for AIDS Research), G. Scott Worthen(Children's Hospital of Philadelphia), Jeremy Katzen(Translational Therapeutics (United States)), Jeffrey H. Lin(University of Pennsylvania), Chaitali Bhadiadra(Children's Hospital of Philadelphia)
Cited by 63
Related Papers
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
|Nature reviews. Immunology|2015|758
The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future
|Cell stem cell|2020|419
Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs
|Proceedings of the National Academy of Sciences|2011|368
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332